Patients are increasingly seen as valuable partners in open innovation. By contributing data through clinical trials and patient registries, they provide crucial insights into the effectiveness of treatments and quality of life outcomes. Patient advocacy groups also play a role in shaping research priorities and ensuring that patient needs are considered in the development of new therapies.
